Cholangiocarcinoma

Clinics in Liver Disease

Volumn 5, Issue 1, 2001, Pages 191-218

  Ahrendt, Steven A ^b   Nakeeb, Attila ^b   Pitt, Henry A ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COMMON BILE DUCT CYST; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; RISK FACTOR; SCLEROSING CHOLANGITIS; TREATMENT PLANNING; ULCERATIVE COLITIS;

EID: 0035140313     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70161-6     Document Type: Article

References (79)

1. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis
2. Current management of patients with perihilar cholangiocarcinoma
3. Primary sclerosing cholangitis: Resect, dilate, or transplant?
4. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis
5. Gallbladder, extrahepatic bile ducts, and ampulla of Vater
6. Percutaneous palliation of malignant obstructive jaundice with wall stent endoprosthesis: Follow-up and reintervention in patients with hilar and non-hilar obstruction
7. Management strategies in resection for hilar cholangiocarcinoma
8. Sclerosing cholangitis: Anatomical distribution of obstructive lesions
9. Hepatic resection and transplantation for peripheral cholangiocarcinoma
10. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage
11. Late development of cholangiocarcinoma after the treatment of hepatolithiasis
12. Intrahepatic cholangiocarcinoma
13. Cytodiagnosis in the management of extrahepatic biliary stricture
14. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival
15. Is angiography useful in patients with perihilar cholangiocarcinoma
16. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer
17. Orthotopic liver transplantation for primary sclerosing cholangitis: A 12-year single center experience
18. Cancer Statistics, 2000
19. Changing trends in the management of extrahepatic cholangiocarcinoma
20. Hilar cholangiocarcinomas T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging
21. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
22. Hilar cholangiocarcinoma: Thin-section spiral CT findings with cholangiographic correlation
23. Cholangiocarcinoma at the hepatic hilus: Sonographic findings
24. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma
25. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
26. Pathomorphologic characteristics of 102 cases of Thorotrast-related hepatocellular carcinoma, cholangiocarcinoma and hepatic angiosarcoma
27. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies
28. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence
29. Radical operation after portal embolization for tumors of the hilar bile duct
30. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
31. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: An unusual tumor with distinctive clinical and pathologic features
32. Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors
33. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction
34. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection
35. Multidisciplinary treatment of biliary tract cancers
36. Choice of palliation for malignant hilar obstruction
37. Cancer statistics, 1998
38. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer
39. Current status of surgical palliation of periampullary carcinoma
40. Choledochal cyst disease: A changing pattern of presentation
41. Magnetic resonance cholangiopancreatography in the diagnosis of biliopancreatic disease
42. Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction
43. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreatobiliary maljunction
44. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma
45. Segmental liver resections for hilar cholangiocarcinoma
46. Biliary CEA levels are a marker for cholangiocarcinoma
47. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors
48. Extended resections for hilar cholangiocarcinoma
49. Unresectable hilar cholangiocarcinoma: Percutaneous versus operative palliation
50. Ki-ras mutations and p53 protein expression in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology
51. Ki-ras point mutations and proliferation activity in biliary tract carcinomas
52. Photodynamic therapy of nonresectable cholangiocarcinoma
53. Phase II trial of intravenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer
54. The management of high-grade hilar structures by endoscopic insertion of self-expanding metal endoprosthesis
55. Factors influencing mortality in biliary tract surgery
56. Malignancies of the biliary tree
57. Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve survival
58. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct
59. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
60. Surgical management of 552 carcinomas of the extrahepatic bile ducts: Results of the French Surgical Association survey
61. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence
62. Cholangiocarcinoma complicating primary sclerosing cholangitis
63. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: A histological analysis of 62 resected cases
64. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
65. Biliary wallstent endoprosthesis in malignant hilar obstruction: Long-term results with regard to the type of obstruction
66. Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease
67. 131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma
68. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma
69. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: A cooperative study of the Keio Bile Duct Cancer Study Group
70. Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile duct dilatation
71. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinoma
72. Carcinoma arising in the wall of congenital bile duct cysts
73. Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens
74. Initially unresectable hilar cholangiocarcinoma hepatic regeneration after transarterial embolization
75. Aggressive surgical resection for cholangiocarcinoma
76. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I Eastern Cooperative Oncology Group Trial
77. Periampullary adenocarcinoma: Analysis of 5 year survivors
78. Mutations of the p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers